Your search returned 984 results.

Results
	441.	Long-term follow-up of clinical trials of multiple sclerosis therapies. [electronic resource] by Freedman, Mark S Producer: 20110127 In: Neurology vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	442.	Predictors of disease activity in 857 patients with MS treated with interferon beta-1b. [electronic resource] by Hartung, Hans-Peter Kappos, Ludwig Goodin, Douglas S O'Connor, Paul Filippi, Massimo Arnason, Barry Comi, Giancarlo Cook, Stuart Jeffery, Douglas Petkau, John White, Richard Bogumil, Timon Beckmann, Karola Stemper, Brigitte Suarez, Gustavo Sandbrink, Rupert Pohl, Christoph Producer: 20160906 In: Journal of neurology vol. 262 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	443.	Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China. [electronic resource] by Xu, Yan Mao, Ningying Chirikov, Viktor Du, Fen Yeh, Yu-Chen Liu, Li Liu, Ruiqi Gao, Xin Producer: 20190408 In: Clinical drug investigation vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	444.	The interferon-beta 1b clinical trial and its implications for other trials. [electronic resource] by Paty, D W Producer: 19940728 In: Annals of neurology vol. 36 Suppl Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	445.	Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. [electronic resource] by Bertolotto, A Malucchi, S Sala, A Orefice, G Carrieri, P B Capobianco, M Milano, E Melis, F Giordana, M T Producer: 20020903 In: Journal of neurology, neurosurgery, and psychiatry vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	446.	[Interferons beta in patients with multiple sclerosis]. [electronic resource] by Vlasov, Ia V Kuznetsova, N I Poverennova, I E Khivintseva, E V Producer: 20051006 In: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 105 Availability: No items available. Save to lists Add to cart (remove)
	447.	[The influence of betaserk and cinarizine on vestibular function, highest nervous activity and brain circulation in chronic cerebral ischemia: a model study]. [electronic resource] by Grishina, T R Gromova, O A Sadin, A V Nazarenko, O A Zhidomorov, N Iu Borzunov, M P Vatsuro, A A Nikonov, A A Producer: 20040712 In: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 104 Availability: No items available. Save to lists Add to cart (remove)
	448.	Disease-modifying drugs in multiple sclerosis. [electronic resource] by Keenan, Elizabeth Porter, Bernadette Producer: 20031104 In: Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	449.	A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type. [electronic resource] by Nikfar, Shekoufeh Rahimi, Roja Abdollahi, Mohammad Producer: 20110304 In: Clinical therapeutics vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	450.	Betaferon efficiency indicators in the treatment of relapsing remitting form of multiple sclerosis. [electronic resource] by Suljic, Enra Sinanovic, Osman Kurtovic-Alajbegovic, Azra Klupka-Saric, Inge Producer: 20140429 In: Medical archives (Sarajevo, Bosnia and Herzegovina) vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	451.	Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study. [electronic resource] by Lus, G Signoriello, E Maniscalco, G T Bonavita, S Signoriello, S Gallo, C Producer: 20161213 In: European journal of neurology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	452.	Cytotoxicity of autologous Epstein-Barr virus-transformed cells mediated by interleukin-2 dependent, long-term T cell cultures is augmented by beta, but not alpha, recombinant interferon. [electronic resource] by Chen, B P Sondel, P M Producer: 19860925 In: Journal of biological response modifiers vol. 5 Availability: No items available. Save to lists Add to cart (remove)
	453.	Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. [electronic resource] by Byrne, G I Lehmann, L K Kirschbaum, J G Borden, E C Lee, C M Brown, R R Producer: 19861217 In: Journal of interferon research vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	454.	gamma-aminobutyric acid-transaminase activity in the human thymus after administration of interferons. [electronic resource] by Cavallotti, D Artico, M D'Andrea, V Cavallotti, C Producer: 20000914 In: Human immunology vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	455.	Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy. [electronic resource] by Genç, K Dona, D L Reder, A T Producer: 19970701 In: The Journal of clinical investigation vol. 99 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	456.	Interferon beta-1b (betaseron/betaferon) is well tolerated at a dose of 500 microg: interferon dose escalation assessment of safety (IDEAS). [electronic resource] by Gottesman, M H Friedman-Urevich, S Producer: 20060731 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	457.	Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis. [electronic resource] by Dressel, A Kolb, A K Elitok, E Bitsch, A Bogumil, T Kitze, B Tumani, H Weber, F Producer: 20070130 In: Acta neurologica Scandinavica vol. 114 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	458.	Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b. [electronic resource] by Lee, Ji I Eisenberg, Stephen P Rosendahl, Mary S Chlipala, Elizabeth A Brown, Jacquelyn D Doherty, Daniel H Cox, George N Producer: 20140731 In: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	459.	Cytokines and disability in interferon-β-1b treated and untreated women with multiple sclerosis. [electronic resource] by Trenova, Anastasiya G Slavov, Georgy S Manova, Maria G Kostadinova, Ivanka I Producer: 20150511 In: Archives of medical research vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	460.	Cutaneous necrotic lesion: A wonderful delay adverse effect of interferon beta-1b injection for multiple sclerosis treatment. [electronic resource] by Mozafari, Nikoo Saffaei, Ali Alizadeh, Mohammad Shabani, Minoosh Producer: 20210118 In: Journal of cosmetic dermatology vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 984 results.